GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Phoenix Biotech Acquisition Corp (NAS:PBAXU) » Definitions » Debt-to-Asset

PBAXU (Phoenix Biotech Acquisition) Debt-to-Asset : 0.17 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Phoenix Biotech Acquisition Debt-to-Asset?

Phoenix Biotech Acquisition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $1.40 Mil. Phoenix Biotech Acquisition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Phoenix Biotech Acquisition's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2023 was $8.47 Mil. Phoenix Biotech Acquisition's debt to asset for the quarter that ended in Sep. 2023 was 0.16.

Phoenix Biotech Acquisition Debt-to-Asset Historical Data

The historical data trend for Phoenix Biotech Acquisition's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phoenix Biotech Acquisition Debt-to-Asset Chart

Phoenix Biotech Acquisition Annual Data
Trend Dec21 Dec22
Debt-to-Asset
- 0.02

Phoenix Biotech Acquisition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.02 0.05 0.08 0.17

Competitive Comparison of Phoenix Biotech Acquisition's Debt-to-Asset

For the Shell Companies subindustry, Phoenix Biotech Acquisition's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phoenix Biotech Acquisition's Debt-to-Asset Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Phoenix Biotech Acquisition's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Phoenix Biotech Acquisition's Debt-to-Asset falls into.


;
;

Phoenix Biotech Acquisition Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Phoenix Biotech Acquisition's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.65 + 0) / 42.367
=0.02

Phoenix Biotech Acquisition's Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.395 + 0) / 8.471
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phoenix Biotech Acquisition  (NAS:PBAXU) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Phoenix Biotech Acquisition Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Phoenix Biotech Acquisition's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Phoenix Biotech Acquisition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Phoenix Biotech Acquisition Corp (NAS:PBAXU) » Definitions » Debt-to-Asset
Comparable Companies
NVAC GMFI FHLT ASPA MAQC EFHT MACA BWAQ FORL KYCH PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
2201 Broadway, Suite 705, Oakland, CA, USA, 94612
Website
Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe.